The Gender Health Gap Is a Feature, Not a Bug

We keep talking about the Gender Health Gap as if it were an unfortunate biological accident. A medical mystery. An inevitability. It isn't.

The Gender Health Gap is a design failure, the predictable outcome of systems built on the wrong assumptions and scaled globally without correction.

The data are consistent across regions and income levels:

• Autoimmune Epidemic: Women represent nearly 80% of people living with autoimmune diseases, conditions closely linked to immune dysregulation and chronic stress.

• Heart Health: Women are approximately 50% more likely to receive an incorrect initial diagnosis for a heart attack, because their symptoms do not match male-derived clinical “norms.”

• Chronic pain: Conditions such as endometriosis take seven to ten years to diagnose, in large part because female pain has been normalized, fragmented, and deprioritized within medical systems.

But to treat this solely as a healthcare problem is to miss the full picture. The same misalignment that degrades women's health also shortens careers, accelerates leadership exits, and drives founder burnout. Reduced representation at senior and decision-making levels then feeds back into continued underinvestment in women's health research and innovation.

The Original Design Flaw: The 24-Hour Default

The foundational mistake is the assumption that the human body resets every 24 hours. This assumption maps cleanly to male biology, where hormonal patterns largely follow a circadian rhythm: testosterone peaks in the morning, supports daytime activity, and resets overnight.

Women's biology, however, functions on two biological clocks simultaneously:

1. 1

   A circadian rhythm (24 hours)

2. 2

   An infradian rhythm (the approximately 28-day cycle)

For decades, medical research treated female biology as "too complex" or a "confounding variable." In Africa, this exclusion was compounded by cultural barriers that often required male consent for women to participate in studies. The result is a global medical knowledge base with strikingly little data on how African women's bodies actually function.

When a cyclical biological system is forced to perform as if it were linear, the cost accumulates silently. Physiologically, this manifests as allostatic load: the cumulative wear and tear caused by chronic stress. This is not a lack of grit; it is the biological pathway to burnout, chronic illness, and poor health outcomes.

When Design Flaws Scale

This male default does not stop at the clinic. It shapes how we work, how we lead, and how capital is allocated.

1. Workplace Design Failure

Modern workplaces reward linear consistency: performing at the same intensity every single day. Because female biology is cyclical, women are often forced to override their physiology to be perceived as "professional."

What we label professionalism is, in practice, a sustained state of physiological override.

Over time, this creates chronic stress and immune dysfunction. The cost is absorbed quietly by women's bodies, their careers, and their earning power.

2. Capital Design Failure

Venture capital is optimized for speed, constant availability, and linear growth. While this model causes burnout across the board, it is particularly hostile to cyclical health realities and caregiving loads. The funding gap is not just a bias layered onto the system; it is produced by the system's operating logic. Women are not underfunded because they lack ambition; they are underfunded because the financial instruments themselves were designed for a different way of building.

Why “Resilience” Is the Wrong Fix

For years, the proposed solution has been to tell women to "lean in," optimize their routines, and build resilience.

This is a distraction.

You cannot "resilience" your way out of a system that was not built for you. You do not fix a failing road by asking people to drive more carefully. Design flaws require redesign, not discipline.

Burnout and the attrition of women leaders are not personal failures. They are the mathematical result of operating inside systems optimized for a physiology women do not have.

Three System Shifts That Will Change the Outcome

Closing the Gender Health Gap requires coordinated, structural change across health, labor, and innovation systems.

1. 1

   From symptoms to signals. We are moving from subjective symptom reporting to objective biological measurement. Emerging biosensors and hormone-tracking technologies make it possible to observe stress and hormonal load in real time. Just as continuous glucose monitors transformed diabetes care, continuous biological monitoring has the potential to transform women's health by making the infradian rhythm visible, measurable, and designable.

2. 2

   From linear productivity to biology-aware work design. Linear productivity models are inefficient for a large portion of the workforce. Aligning different types of work with different phases of the infradian cycle, for example creative and strategic work during the follicular phase and analytical execution during the luteal phase, is not accommodation; it is optimization. Organizations that design with biology rather than against it see gains in both performance and sustainability.

3. 3

   From traditional venture capital to structural innovation models. Despite growing awareness, women's health innovation remains underfunded. In recent years, companies founded solely by women have received only a small fraction of total venture capital. Venture studios offer a structural alternative: shared operational infrastructure that reduces early-stage risk, mitigates founder burnout, and allows innovation to focus on outcomes rather than survival.

The Leapfrog Opportunity

This is not only a health equity issue; it is an economic imperative. The United Nations Development Programme estimates that gender inequality costs Sub-Saharan Africa approximately $95 billion annually. Conversely, McKinsey estimates that advancing women's equality could add $316 billion to Africa's GDP.

While Western systems struggle to retrofit legacy institutions, emerging markets hold a strategic advantage: we can leapfrog directly to biology-aware models.

This is precisely the gap Daya Africa is addressing.

Daya operates as a Venture Studio, a structural alternative to traditional Accelerator programs; optimised for biological reality rather than burnout economics. By providing shared operational infrastructure, we reduce the pressure that drives founder exhaustion. We are proving that systems can be designed where women's health is the foundation, not an add-on, whether through privacy-first supply chains or workflows that honour infradian rhythms.

Inclusive design is not charity. It is a competitive advantage.

The Bottom Line

The Gender Health Gap is not destiny, nor is it an accident of nature. It is a choice.

Existing systems were designed around male physiology and incentives, but design choices can be changed. Once female biology is treated as a design requirement rather than a deviation, different outcomes become possible for health systems, labor markets, and entire economies.

The question is no longer whether the gap can be closed. It is whether we are willing to redesign the systems that produce it.